Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS)

Clinical trial NCT00854646 · COMPLETED

Trial details

NCT number: NCT00854646
Sponsor: Traws Pharma, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myelocytic Leukemia Acute Lymphocytic Leukemia Chronic Myelocytic Leukemia Chronic Lymphocytic Leukemia Myelodysplastic Syndromes

Start date: 2008-10-01
Primary completion: 2014-11-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.